PERCEVAL Pivotal Trial

Status Completed

Clinical Trial Summary

The clinical investigation is designed as a prospective and non-randomised study on a maximum of 150 patients. This study will be conducted at Investigational Centres in the European Community. A minimum number of 8 European Centres will be involved in the clinical investigation. A minimum of 15 patients will be enrolled at each Investigational Centre. The clinical follow-up requires evaluations at discharge (or 30 days if the patient is still hospitalized), 3-6 and 12 months following the procedure.The primary objective of this clinical investigation is to assess the performance of the Perceval S valve at 3-6 months after implantation in high surgical risk patients, who require a surgical intervention to replace the aortic valve.

Clinical Trial Description

The design of the Perceval S prosthesis stems from the intention to offer an alternative to traditional flexible prostheses (stented and stentless biological valves) using conventional open-heart surgery. As a result of the sutureless implant procedure, in fact, patients could benefit from: Reducing aortic clamp times, with subsequent overall reduction of surgical timing and therefore reduction in related risks; Avoiding to pass the stitches through the annulus and sutures knotting, with consequent less risk of tearing aortic annulus and wall, damaging the bundle of His, embolizing foreign material in the vascular system. ;

Study Design

Related Conditions & MeSH terms

Aortic Valve Replacement

Clinical Trial Details

NCT number	NCT00860730
Study type	Interventional
Source	Corcym S.r.l
Contact
Status	Completed
Phase	N/A
Start date	January 2009
Completion date	October 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00774293` - Homoeopathic Association in Aortic Valve Surgery	Phase 4
Completed	`NCT05107453` - Serratus Anterior Plane Block for Minimal Invasive Cardiac Surgery	Phase 4
Completed	`NCT01651780` - Open-label, Randomized Trial in Patients Undergoing TAVR to Determine Safety & Efficacy of Bivalirudin vs UFH	Phase 3
Completed	`NCT01187329` - The Effect of the Hyperinsulinemic Normoglycemic Clamp on Myocardial Function and Utilization of Glucose	N/A
Recruiting	`NCT05295628` - Evaluation of Safety and Effectiveness of the EMBLOK EPS During TAVR	N/A
Enrolling by invitation	`NCT03680040` - RESILIENCE Trial: Evaluation of the Durability of Aortic Bioprostheses/Valves With RESILIA Tissue in Subjects Under 65
Recruiting	`NCT05539937` - Prospective Evaluation of the Quality of Life of Elderly Patients Undergoing Transfemoral Percutanous Aortic Valve Replacement (TAVI) for the Treatment of Severe Aortic Stenosis.
Recruiting	`NCT01522352` - Comparison Between Three Types of Stented Pericardial Aortic Valves	N/A
Completed	`NCT01554709` - Safety and Performance Study of the CardioGard Cannula	Phase 2/Phase 3
Suspended	`NCT04902053` - INSPIRIS RESILIA Aortic Valve, Valve-in-Valve Surveillance Study
Completed	`NCT01404975` - TAVI Protocol - Paravertebral Block Study	N/A
Recruiting	`NCT03889288` - Innovative Device for Pain Management by Millimeter Band Radiation: Electronic-Pain Killer	N/A
Active, not recruiting	`NCT05404880` - INSPIRIS China PMCF Study
Recruiting	`NCT04652375` - Outcomes After Albumin vs Lactated Ringer's Solution in CABG and AVR Procedures	N/A
Recruiting	`NCT06106451` - Optimization Post-TAVR to IMprove Activity Levels (OPTIMAL Study)	N/A
Active, not recruiting	`NCT00396760` - Comparison of Aprotinin and Tranexamic Acid in Routine Cardiac Surgery	Phase 3
Not yet recruiting	`NCT03603483` - Aortic Root Enlargement in Aortic Valve Replacement	N/A
Terminated	`NCT01368666` - Safety and Effectiveness Study of Perceval S Valve for Extended CE Mark	N/A
Recruiting	`NCT03002272` - Transcatheter Aortic Prosthesis Function: A Long-term Follow-up Study
Active, not recruiting	`NCT03258333` - Small Aortic Annulus - a New Solution to the Old Problem	N/A